Tag: Veeda Clinical Research

By leveraging Mango Sciences’ AI-powered Querent™ platform, Veeda will effectively use technology to automate patient identification with precision and expand its reach across Europe

Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research Limited shares his vision for the company, latest developments, long-term growth, industry trends and future outlook

The Cover Story focuses on the impact of BIOE3 policy. Read Special Interview of Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research. Expert Insights by Dr Prabhu Vinayagam, Medical Advisor, Orchid AMS and Shashank Avadhani, CEO and Co-founder, Alyve Health. Special stories on MPox virus, AMR and AgriTech.

With this acquisition, Veeda’s global pharmaceutical and biotech clients can now leverage the unique and unparalleled suite of early to late-phase CRO services across Europe, US, and Asia Pacific

Dr Sanjib Banerjee, Chief Operating Officer (Biopharma division), Veeda Clinical Research Limited explains the latest industry trends and initiatives being undertaken by his company

Post pandemic, Indian Contract Research Organizations have re-engineered their resources to tap the increasing demand from North America and Europe, writes Dr Kiran Marthak

Click to Read: January 2023 Edition of BioVoice eMagazine BioVoice News, India's leading B2B news media for BioTech, HealthTech and AgriTech, is celebrating its 7th anniversary...

This edition of Chat with BioVoice features Ajay Tandon, Managing Director, Veeda Clinical Research Limited